# Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19

> **NCT04381377** · PHASE2,PHASE3 · COMPLETED · sponsor: **NPO Petrovax** · enrollment: 394 (actual)

## Conditions studied

- Infections, Coronavirus

## Interventions

- **DRUG:** azoximer bromide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04381377
- **Lead sponsor:** NPO Petrovax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-04-23
- **Target enrollment:** 394 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04381377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04381377, "Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04381377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*